Section Arrow
Quote
CDIO.NASDAQ
- Cardio Diagnostics Holdings Inc.
Quotes are at least 15-min delayed:2026/04/21 21:21 EDT
Regular Hours
Last
 1.88
-0.09 (-4.57%)
Day High 
1.9612 
Prev. Close
1.97 
1-M High
2.47 
Volume 
54.57K 
Bid
1.89
Ask
1.97
Day Low
1.86 
Open
1.93 
1-M Low
1.66 
Market Cap 
5.83M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.95 
20-SMA 1.98 
50-SMA 2.78 
52-W High 15 
52-W Low 0.97 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.71/--
Enterprise Value
6.02M
Balance Sheet
Book Value Per Share
2.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
14.83K
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1968-0.0651-24.86%-- 
XRTXXORTX Therapeutics Inc.2.69+0.44+19.56%-- 
TOVXTheriva Biologics Inc0.3387-0.0713-17.39%0.09PE
GERNGeron Corp1.5-0.06-3.85%-- 
SPRCSciSparc Ltd.5.99+1.76+41.61%0PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.